Your browser doesn't support javascript.
loading
Comparison of the Pharmacokinetics of the Phase II and Phase III Capsule Formulations of Selumetinib and the Effects of Food on Exposure: Results From Two Randomized Crossover Trials in Healthy Male Subjects.
Tomkinson, Helen; McBride, Eileen; Martin, Paul; Lisbon, Eleanor; Dymond, Angela W; Cantarini, Mireille; So, Karen; Holt, David.
Afiliación
  • Tomkinson H; AstraZeneca, Macclesfield, United Kingdom. Electronic address: helen.tomkinson@astrazeneca.com.
  • McBride E; AstraZeneca, Macclesfield, United Kingdom.
  • Martin P; AstraZeneca, Macclesfield, United Kingdom.
  • Lisbon E; Quintiles Phase I Services, Overland Park, Kansas, United States.
  • Dymond AW; AstraZeneca, Macclesfield, United Kingdom.
  • Cantarini M; AstraZeneca, Macclesfield, United Kingdom.
  • So K; AstraZeneca, Macclesfield, United Kingdom.
  • Holt D; AstraZeneca, Macclesfield, United Kingdom.
Clin Ther ; 39(11): 2260-2275.e1, 2017 Nov.
Article en En | MEDLINE | ID: mdl-28985960
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Bencimidazoles / Interacciones Alimento-Droga / Composición de Medicamentos Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Clin Ther Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Bencimidazoles / Interacciones Alimento-Droga / Composición de Medicamentos Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Clin Ther Año: 2017 Tipo del documento: Article